Galderma Group Dividends and Buybacks
Dividend criteria checks 0/6
Galderma Group is a dividend paying company with a current yield of 0.14%.
Key information
0.1%
Dividend yield
-7.1%
Buyback Yield
Total Shareholder Yield | -7.1% |
Future Dividend Yield | 0.6% |
Dividend Growth | n/a |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Payout ratio | n/a |
Recent dividend and buyback updates
Recent updates
Investors Appear Satisfied With Galderma Group AG's (VTX:GALD) Prospects As Shares Rocket 28%
May 20
Nemluvio Launch And Global Expansion Will Shape Therapeutic Dermatology Markets
Launch of Nemluvio and international expansion in China and India are expected to significantly boost revenue growth and market share.The Price Is Right For Galderma Group AG (VTX:GALD) Even After Diving 27%
Apr 05Galderma Group AG Just Beat EPS By 26%: Here's What Analysts Think Will Happen Next
Mar 08Is There An Opportunity With Galderma Group AG's (VTX:GALD) 50% Undervaluation?
Dec 18These 4 Measures Indicate That Galderma Group (VTX:GALD) Is Using Debt Reasonably Well
Oct 27Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if GALD's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if GALD's dividend payments have been increasing.
Dividend Yield vs Market
Galderma Group Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (GALD) | 0.1% |
Market Bottom 25% (CH) | 1.9% |
Market Top 25% (CH) | 3.8% |
Industry Average (Pharmaceuticals) | 3.3% |
Analyst forecast (GALD) (up to 3 years) | 0.6% |
Notable Dividend: GALD's dividend (0.14%) isn’t notable compared to the bottom 25% of dividend payers in the Swiss market (1.89%).
High Dividend: GALD's dividend (0.14%) is low compared to the top 25% of dividend payers in the Swiss market (3.83%).
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate GALD's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as GALD has not reported any payouts.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/05/27 08:04 |
End of Day Share Price | 2025/05/27 00:00 |
Earnings | 2024/12/31 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Galderma Group AG is covered by 20 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Fulvio Cazzol | Berenberg |
Bethan Davies | Berenberg |
Victor Floch | BNP Paribas Exane |